Commercial Support Acknowledgment

This educational activity is supported by an educational grant from GlaxoSmithKline.

Unapproved Use Disclosure

The Duke University School of Medicine requires CME faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Staff and Content Validation Reviewer Disclosure

The staff involved with this activity and any content validation reviewers of this activity have reported no relevant financial relationships with commercial interests.

Resolution of Conflicts of Interest

In accordance with the ACCME Standards for Commercial Support of CME, the Duke University School of Medicine will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Planning Committee and Faculty Disclosure

The following speakers and/or planning committee members have indicated they have no relationships with industry to disclose relative to the content of this CME activity:

• Theodore Bruno, MD
• Wendy Scales, PhD
• Heather Tarbox, MPH

The following speakers and/or planning committee members have indicated that they have relationships with industry to disclose:

• David M. Albala, MD, FACS, fulfills the role of Speaker for GlaxoSmithKline, Applied Medical, Boehringer Ingelheim, and sanofi-aventis.
• Louis Kuritzky, MD, fulfills the role of Advisory Board member for Eli Lilly/sanofi-aventis, sanofi-aventis, and Takeda. He fulfills the role of Speaker for Eli Lilly/sanofi-aventis, Novartis-NovoNordisk, sanofi-aventis, and Takeda. He fulfills the role of Consultant for Novartis-NovoNordisk and is an Independent Contractor for Amylin.
• Michael J. Naslund, MD, fulfills the role of Speaker for GlaxoSmithKline and sanofi-aventis.